Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Leone

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Oncogene|April 18, 2024
Correction: A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformationE Grassilli, F Pisano, A Cialdella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Deletions of CDKN2C in multiple myeloma: biological and clinical implicationsPaola E Leone, Brian A Walker, Matthew W Jenner, et al.
International Journal of Geriatric Psychiatry|August 7, 2010
Diagnostic criteria for apathy in clinical practiceE Mulin, E Leone, K Dujardin, et al.
Scientific Reports|June 27, 2019
The three-hybrid genetic composition of an Ecuadorian population using AIMs-InDels compared with autosomes, mitochondrial DNA and Y chromosome dataAna Karina Zambrano, Aníbal Gaviria, Santiago Cobos-Navarrete, et al.
The Journal of Pathology|September 14, 2019
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancersMarialuisa Lavitrano, Leonarda Ianzano, Sara Bonomo, et al.
Blood|July 10, 2010
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic valueBrian A Walker, Paola E Leone, Laura Chiecchio, et al.
Cell Death & Disease|November 30, 2012
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1N Amodio, M T Di Martino, U Foresta, et al.
Blood|July 5, 2007
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myelomaMatthew W Jenner, Paola E Leone, Brian A Walker, et al.
Journal for Immunotherapy of Cancer|October 12, 2024
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesisElena Daveri, Barbara Vergani, Luca Lalli, et al.
Molecular Genetics & Genomic Medicine|December 13, 2019
Multi-institutional experience of genetic diagnosis in Ecuador: National registry of chromosome alterations and polymorphismsCésar Paz-Y-Miño, Verónica Yumiceba, Germania Moreta, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Oncogene|April 18, 2024
Correction: A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformationE Grassilli, F Pisano, A Cialdella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Deletions of CDKN2C in multiple myeloma: biological and clinical implicationsPaola E Leone, Brian A Walker, Matthew W Jenner, et al.
International Journal of Geriatric Psychiatry|August 7, 2010
Diagnostic criteria for apathy in clinical practiceE Mulin, E Leone, K Dujardin, et al.
Scientific Reports|June 27, 2019
The three-hybrid genetic composition of an Ecuadorian population using AIMs-InDels compared with autosomes, mitochondrial DNA and Y chromosome dataAna Karina Zambrano, Aníbal Gaviria, Santiago Cobos-Navarrete, et al.
The Journal of Pathology|September 14, 2019
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancersMarialuisa Lavitrano, Leonarda Ianzano, Sara Bonomo, et al.
Blood|July 10, 2010
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic valueBrian A Walker, Paola E Leone, Laura Chiecchio, et al.
Cell Death & Disease|November 30, 2012
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1N Amodio, M T Di Martino, U Foresta, et al.
Blood|July 5, 2007
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myelomaMatthew W Jenner, Paola E Leone, Brian A Walker, et al.
Journal for Immunotherapy of Cancer|October 12, 2024
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesisElena Daveri, Barbara Vergani, Luca Lalli, et al.
Molecular Genetics & Genomic Medicine|December 13, 2019
Multi-institutional experience of genetic diagnosis in Ecuador: National registry of chromosome alterations and polymorphismsCésar Paz-Y-Miño, Verónica Yumiceba, Germania Moreta, et al.
Pageof 20